Dec 11, 2018
Magnetic Resonance Imaging (MRI) can be used to provide quantitative measurements in the form of imaging biomarkers. These measurements have a number of attractive characteristics: They are non-invasive, can provide organ and lesion localisation of morphology, physiology and metabolism and can be repeated over time.
These characteristics enable monitoring of the biological impact of drugs and can be helpful in patient selection. With appropriate deployment they can assist in go/no-go decision making and in some cases can provide endpoints for late stage trials.
This episode describes the deployment and potential benefit of MRI biomarkers via a number of examples of their use in drug development in different disease areas.
Original article by Dr Geoff J.M. Parker
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
https://www.ddw-online.com/media/32/100469/seeing-within-magnetic-resonance-imaging.pdf
For more information on Drug Discovery World, head to: